Introduction
Synexa is a global leader in biomarker and bioanalytical science, with deep expertise in the immunological underpinning of health and disease.
We offer a comprehensive range of analytical and advisory services to clients comprising the identification, development,
validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our developing global network of labs serve our client base of primarily Biotech and Pharma companies, either directly or via a CRO.
We are dedicated to providing quality, clinically relevant solutions, and all activities across all our sites are performed in
compliance with GCLP which incorporate the relevant GCP/GLP guidelines, under the guidance and watchful eyes of our Quality Assurance team.

DNA
- Targeted PGx
- Microarray
- Sequencing
- Electrophoresis

RNA
- NanoString
- RT-qPCR
- PCR expression array

Protein
- ELISA, CBA & MesoScale
- ELISpot
- Protein arrays
- Nephelometry
- Fluorescence and luminescence based assays

Cell
- Flow cytometry
- Sorting
- Cell Culture assays
- Circulating Tumor Cells (CTC)
- Fluorescence Microscopy
- Microbiology

Tissue
- NanoString
- Organotypic culture
Bioanalytical
services
ProtoTrials®
Our human in vitro translational
ProtoTrials® platform bridges the gap
between animal models and humans
and is ideal for applications within PD,
Safety, Drug Benchmarking and
Biomarker Discovery.
Bioanalysis
Biomarkers
Novel Modality Bioanalytics
Custom Assay Solutions
Areas of Specialty
Therapeutic expertise and research phase expertise
- Immunology
- Autoimmune
- Oncology
- Neurological
- Rare diseases
- And others as required
Our Global Laboratory Network
- Lab Location
- Office Location
- Lab/Office Location